Clinical Trials Directory

Trials / Unknown

UnknownNCT02430584

Whole Blood Specimen Collection From Pregnant Subjects

Status
Unknown
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Progenity, Inc. · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

To obtain whole blood specimens from pregnant subjects to be used for research and development and clinical validation studies of prenatal assays.

Detailed description

This sample collection protocol allows for the identification, recruitment, and participation in women who are pregnant and are known to: 1. be at an increased risk for fetal genetic abnormalities 2. be at increased risk for congenital fetal infection by virtue of being positive by initial screening tests, or are known to have an active infection during this pregnancy. 3. possess irregular blood group antigens (the subject or the father of the baby) and are therefore at increased risk for fetal sensitization during this pregnancy.

Conditions

Interventions

TypeNameDescription
OTHERObservational - no intervention

Timeline

Start date
2015-03-01
Primary completion
2021-03-01
Completion
2021-05-01
First posted
2015-04-30
Last updated
2020-09-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02430584. Inclusion in this directory is not an endorsement.